Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 2, 2006, Pages

  Bahr, Matthias J ^a   Ockenga, Johann ^a,b   Boker, Klaus H W ^a   Manns, Michael P ^a   Tietge, Uwe J F ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Body composition; Hepatic turnover; Liver; Portal pressure

Indexed keywords

FATTY ACID; GLUCOSE; KETONE BODY; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CIRCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY METABOLISM; GLUCONEOGENESIS; GLUCOSE METABOLISM; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; CYTOKINES; FEMALE; GLUCOSE; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RESISTIN;

EID: 33745844781     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00291.2005     Document Type: Article

References (52)

1. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, and Lazar MA. Regulation of fasted blood glucose by resistin. Science 303: 1195-1198, 2004.
2. Chen L and Nyomba BL. Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet. Endocrinology 144: 500-508, 2003.
3. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, and Considine RV. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88: 5452-5455, 2003.
4. Fain JN, Cheema PS, Bahouth SW, and Hiler ML. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300: 674-678, 2003.
5. Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, and Cao H. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 23: 111-116, 2003.
6. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, and Smith SR. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89: 1844-1848, 2004.
7. Hilleman MR. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc Natl Acad Sci USA 101, Suppl 2: 14560-14566, 2004.
8. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
9. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB Jr, Peale FV, Shelton DL, and Hebert CC. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19: 4046-4055, 2000.
10. Housova J, Anderlova K, Krizova J, Haluzikova D, Kremen J, Kumstyrova T, Papezova H, and Haluzik M. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90: 1366-1370, 2005.
11. Juan CC, Au LC, Fang VS, Kang SF, Ko YH, Kuo SF, Hsu YP, Kwok CF, and Ho LT. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 289: 1328-1333, 2001.
12. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, and Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309: 286-290, 2003.
13. Kershaw EE and Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556, 2004.
14. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, and Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 42: 62-66, 2003.
15. Kim KH, Lee K, Moon YS, and Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276: 11252-11256, 2001.
16. Kruszynska Y, Home PD, and McIntyre N. Relationship between insulin insensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14: 103-111, 1991.
17. Lay SL, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, Valet P, and Dugail I. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 289: 564-567, 2001.
18. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, and Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856, 2003.
19. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, and Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1: e45, 2004.
20. Lin SY, Sheu WHH, Chen WY, Lee FY, and Huang CJ. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha. Mol Cell Endocrinol 232: 1-8, 2005.
21. Lu SC, Shieh WY, Chen CY, Hsu SC, and Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530: 158-162, 2002.
22. Lumsden AB, Henderson JM, and Kutner MH. levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232-236, 1988.
23. Makimura H, Mizuno TM, Bergen H, and Mobbs CV. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab 283: E1266-E1271, 2002.
24. McCullough AJ and Raguso C. Effect of cirrhosis on energy expenditure. Am J Clin Nutr 69: 1066-1068, 1999.
25. Müller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz HU, Burger M, Balks HJ, von zur Muhlen A, and Schmidt FW. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 102: 2033-2041, 1992.
26. Müller MJ, Böker KHW, and Selberg O. Metabolism of energy-yielding substrates in patients with liver cirrhosis. Clin Investig 72: 568-579, 1994.
27. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114: 232-239, 2004.
28. Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E, Andrighetto G, Federspil G, and Vettor R. Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 90: 4335-4340, 2005.
29. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, Pulvirenti A, Leao AA, Calori G, Romito R, Baratti D, and Luzi L. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 31: 694-703, 2000.
30. Perseghin G, Caumo A, Mazzaferro V, Pulvirenti A, Sereni LP, Romito R, Lattuada G, Coppa J, Costantino F, Regalia E, and Luzi L. Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation. Transplantation 76: 697-702, 2003.
31. Petrides AS and DeFronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol 8: 107-114, 1989.
32. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, Barzilai N, and Scherer PE. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 16: 1920-1930, 2002.
33. Rangwala SM, Rich AS, Rhoades B, Shapiro JS, Obici S, Rossetti L, and Lazar MA. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53: 1937-1941, 2004.
34. Record CO. Glucose and insulin metabolism in cirrhosis. Adv Exp Med Biol 420: 229-233, 1997.
35. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, and Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939, 2005.
36. Roden M and Bernroider E. Hepatic glucose metabolism in humans - its role in health and disease. Best Pract Res Clin Endocrinol Metab 17: 365-383, 2003.
37. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, and O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202, 2001.
38. Schaffler A, Buchler C, Muller-Ladner U, Herfarth H, Ehling A, Paul G, Scholmerich J, and Zietz B. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 36: 702-707, 2004.
39. She H, Xiong S, Hazra S, and Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280: 4959-4967, 2005.
40. Shmueli E, Record CO, and Alberti KGMM. Liver disease, carbohydrate metabolism and diabetes. Clin Endocrinol Metab 6: 719-744, 1992.
41. Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, and Murphy LJ. Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet Med 21: 497-499, 2004.
42. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001.
43. Steppan CM and Lazar MA. The current biology of resistin. J Intern Med 255: 439-447, 2004.
44. Tietge UJF, Bahr MJ, Manns MP, and Boker KHW. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation. Liver Transpl 7: 1015-1022, 2001.
45. Tietge UJF, Bahr MJ, Manns MP, and Boker KHW. Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones. Clin Transplant 16: 9-17, 2002.
46. Tietge UJF, Bahr MJ, Manns MP, and Boker KHW. Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation. Transplantation 75: 804-810, 2003.
47. Tietge UJF, Boker KHW, Manns MP, and Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 287: E82-E89, 2004.
48. Tietge UJF, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W, Muller MJ, Manns MP, and Boker KHW. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Liver Transpl 10: 1030-1040, 2004.
49. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, and Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103: 264-274, 1992.
50. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, and Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12: 962-971, 2004.
51. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, and Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53: 1279-1284, 2004.
52. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, and Park KS. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89: 150-156, 2004.